162 related articles for article (PubMed ID: 6375862)
1. Carcinogenicity of antineoplastic agents in man.
Rieche K
Cancer Treat Rev; 1984 Mar; 11(1):39-67. PubMed ID: 6375862
[TBL] [Abstract][Full Text] [Related]
2. Second cancers following antineoplastic therapy.
Dorr FA; Coltman CA
Curr Probl Cancer; 1985 Feb; 9(2):1-43. PubMed ID: 3888536
[TBL] [Abstract][Full Text] [Related]
3. [Secondary carcinoma: a complication of cytostatic therapy?].
Queisser W; Kalb M
Med Klin; 1979 Oct; 74(40):1422-30. PubMed ID: 492063
[No Abstract] [Full Text] [Related]
4. Malignancies induced by drug therapy: a review.
Penn I
IARC Sci Publ; 1986; (78):13-27. PubMed ID: 3294589
[No Abstract] [Full Text] [Related]
5. Carcinogenic effects of chemotherapeutic compounds.
Klein-Szanto AJ
Prog Clin Biol Res; 1992; 374():167-74. PubMed ID: 1620702
[No Abstract] [Full Text] [Related]
6. Occurrence of second tumors in man after anticancer drug treatment.
Schmähl D; Habs M; Lorenz M; Wagner I
Cancer Treat Rev; 1982 Sep; 9(3):167-94. PubMed ID: 7159878
[No Abstract] [Full Text] [Related]
7. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
[TBL] [Abstract][Full Text] [Related]
8. Secondary malignancies following cancer chemotherapy.
Boffetta P; Kaldor JM
Acta Oncol; 1994; 33(6):591-8. PubMed ID: 7946433
[TBL] [Abstract][Full Text] [Related]
9. Second neoplasm--a complication of cancer chemotherapy.
Chabner BA
N Engl J Med; 1977 Jul; 297(4):213-5. PubMed ID: 876277
[No Abstract] [Full Text] [Related]
10. Carcinogenic action of anticancer drugs with special reference to immunosuppression.
Schmähl D
Cancer; 1977 Oct; 40(4 Suppl):1927-9. PubMed ID: 332335
[TBL] [Abstract][Full Text] [Related]
11. [Carcinogenicity of anticancer agents].
Hayashi Y; Takahashi M; Yoshimura H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2293-8. PubMed ID: 2260866
[TBL] [Abstract][Full Text] [Related]
12. [CHEMOTHERAPY OF MALIGNANT NEOPLASMS].
KROESE WF; BREUR K
Ned Tijdschr Geneeskd; 1964 Dec; 108():2357-62. PubMed ID: 14260300
[No Abstract] [Full Text] [Related]
13. Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens.
Hazleman B
Am J Med; 1985 Jan; 78(1A):39-43. PubMed ID: 3970039
[TBL] [Abstract][Full Text] [Related]
14. Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.
Clarysse A; Kenis Y; Mathe G
Recent Results Cancer Res; 1976; (53):1-552. PubMed ID: 189368
[No Abstract] [Full Text] [Related]
15. Second malignancies and chemotherapeutic agents.
Kyle RA
Prog Clin Biol Res; 1983; 132E():45-54. PubMed ID: 6417671
[No Abstract] [Full Text] [Related]
16. Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
Petru E; Schmähl D
Neoplasma; 1991; 38(2):147-55. PubMed ID: 2041574
[TBL] [Abstract][Full Text] [Related]
17. Review of United States data on neoplasms in rheumatoid arthritis.
Castor CW; Bull FE
Am J Med; 1985 Jan; 78(1A):33-8. PubMed ID: 3970038
[TBL] [Abstract][Full Text] [Related]
18. Risk of a second malignancy related to the use of cytotoxic chemotherapy.
Reimer RR
CA Cancer J Clin; 1982; 32(5):286-92. PubMed ID: 6811108
[No Abstract] [Full Text] [Related]
19. Carcinogenic potency of alkylating agents in rodents and humans.
Dedrick RL; Morrison PF
Cancer Res; 1992 May; 52(9):2464-7. PubMed ID: 1568217
[TBL] [Abstract][Full Text] [Related]
20. Leukemia following chemotherapy for ovarian cancer.
Kaldor JM; Day NE; Pettersson F; Clarke EA; Pedersen D; Mehnert W; Bell J; Høst H; Prior P; Karjalainen S
N Engl J Med; 1990 Jan; 322(1):1-6. PubMed ID: 2104664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
